U.S. Hemophilia Treatment Market is adopting Gene Therapy Trends
The U.S. hemophilia treatment market is primarily engaged in manufacturing recombinants coagulation factor concentrates, plasma derived concentrates, desmopressin, and anti-inhibitors for treating hemophilia A and …